Episode Details

Back to Episodes
BioNTech Shifts Focus, Cuts Vaccine Production

BioNTech Shifts Focus, Cuts Vaccine Production

Published 2 weeks, 2 days ago
Description

BioNTech, the German biotech firm known for its mRNA COVID vaccine with Pfizer, is ending its vaccine production. Theyre transferring this to Pfizer and closing sites in Germany, Singapore, and more. The shift focuses on cancer treatments and other diseases, with job losses and financial struggles. Theyre investing heavily in research, betting on Pumitamig for multiple cancers, aiming to transform mRNA tech from pandemic hero to oncology game-changer.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/828de9c5aa68b299

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us